Literature DB >> 14122799

POLYMYXIN B AND COLISTIN. A CRITICAL COMPARISON.

N M NORD, P D HOEPRICH.   

Abstract

Keywords:  COLISTIN; DRUG RESISTANCE, MICROBIAL; EXPERIMENTAL LAB STUDY; KIDNEY DISEASES; MICE; PATHOLOGY; POLYMYXIN; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14122799     DOI： 10.1056/NEJM196405142702002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

Review 1.  The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

Authors:  Matthew E Falagas; Sofia K Kasiakou; Sotirios Tsiodras; Argyris Michalopoulos
Journal:  Clin Med Res       Date:  2006-06

Review 2.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

3.  In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.

Authors:  Kady Phe; Yuman Lee; Patrick M McDaneld; Nishant Prasad; Taijun Yin; Deborah A Figueroa; William L Musick; Jessica M Cottreau; Ming Hu; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

4.  Antibiotics, infection and immunological aspects of burns.

Authors:  L R Chasmar
Journal:  Can Med Assoc J       Date:  1967-08-26       Impact factor: 8.262

5.  Melatonin attenuates colistin-induced nephrotoxicity in rats.

Authors:  Jumana M Yousef; Gong Chen; Prue A Hill; Roger L Nation; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 6.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

7.  Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria.

Authors:  Kade D Roberts; Mohammad A K Azad; Jiping Wang; Andrew S Horne; Philip E Thompson; Roger L Nation; Tony Velkov; Jian Li
Journal:  ACS Infect Dis       Date:  2015-09-04       Impact factor: 5.084

8.  Polymyxins as inhibitors of polyclonal B-cell activators in murine lymphocyte cultures.

Authors:  T Butler; E Smith; L Hammarström; G Möller
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

9.  Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria.

Authors:  John P Ouderkirk; Jill A Nord; Glenn S Turett; Jay Ward Kislak
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock.

Authors:  Suresh Ramasubban; Ayanava Majumdar; Purnendu Sekhar Das
Journal:  Indian J Crit Care Med       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.